Device Trial Radar · NCT07193017
The Effect of BIPAP on Diaphragmatic Function
Last checked: Nov 19, 2026Latest source record: Nov 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
30
Planned (sponsor's estimate)
Start
Oct 15, 2025
Primary completion
Mar 15, 2027
Study completion Jun 15, 2027
Sponsor
- Lead sponsor
- Istanbul Demiroglu Bilim UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Istanbul Sureyyapasa Chest Diseases and Chest Surgery Training and Research Hospital
- First posted
- Sep 25, 2025
Design
- Study type
- Observational
- FDA-regulated device
- No
- Who can join
- All sexes, from 40 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This research is designed to evaluate how long-term treatment with Bilevel Positive Airway Pressure (BiPAP) influences diaphragm function in patients with Chronic Obstructive Pulmonary Disease (COPD) who suffer from chronic hypercapnic respiratory failure. The diaphragm is the primary muscle of breathing, and its dysfunction is linked to unfavorable clinical outcomes such as higher mortality rates and frequent hospitalizations. In this prospective cohort study, COPD patients starting BiPAP therapy based on clinical indication will be monitored through repeated ultrasound assessments of diaphragm structure and function together with pulmonary function testing, respiratory muscle strength evaluation, dyspnea. The main outcome of interest is the change in diaphragm thickness in inspiration, thickness in expiration, diaphragm thickening fraction (DTF), diaphragm maximum contraction velocity and maximum relaxation velocity across a 6 weeks as a early time and 12 months for long time follow-up period. Secondary measures include hospital admissions, and one-year survival. The study is expected to generate valuable evidence about the link between non-invasive ventilation and diaphragm function, which may contribute to optimizing treatment strategies for COPD patients with advanced respiratory failure.
Conditions
- BIPAP Biphasic Intermittent Positive Airway Pressure
- Diaphragm Issues
- Ultrasound Diagnostics
- COPD (Chronic Obstructive Pulmonary Disease)
Interventions
BIPAPDevice
After BIPAP Prescribed By A Physician, Diaphragmatic Functions Will Be Evaluated With Ultrasound In The Early And Late Periods
Primary outcomes
What the sponsor says the trial is designed to measure.
- One-Year SurvivalTime frame: at baseline and after 12 months
- Number of Hospital Admissions within 12 MonthsTime frame: at baseline and after 12 months
- Maximum Inspiratory Pressure (MIP)Time frame: Baseline, after 6 weeks of BiPAP usage, and after one year
8 more outcomes with a free account
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Demiroglu Bilim University, Department of Physiotherapy and Rehabilitation
Istanbul, Turkey (Türkiye)
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.